Evaluation of immunotherapy to reverse sequestration in the treatment of severe Plasmodium falciparum malaria

Immunology and Cell Biology

Volumn 82, Issue 4, 2004, Pages 447-452

  Goldring, J P Dean ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Antibodies; Immunotherapy; Malaria; Plasmodium; Sequestration

Indexed keywords

ANTIBODY; LIGAND; QUININE; RECEPTOR;

ANTIBODY BLOOD LEVEL; ARTICLE; CALCULATION; CELL ADHESION; CLINICAL OBSERVATION; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); DISEASE SEVERITY; DRUG UTILIZATION; DYNAMICS; EVALUATION; HEMOCONCENTRATION; HOST; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; MALARIA; PARASITE; PATIENT; PLASMODIUM FALCIPARUM; PROTEIN EXPRESSION;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 4344650352     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0818-9641.2004.01265.x     Document Type: Article

References (51)

1. Bignami A, Bastianelli G. Observation of estivo-autumnal malaria. Rioforma Med. 1890; 223: 1334-5.
2. Macpherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA. Human cerebral malaria: a quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 1985; 119: 385-401.
3. Maubert B, Guilbert LJ, Deloron P. Cytoadherence of Plasmodium falciparum to intercellular adhesion molecule 1 and chondroitin-4-sulfate expressed by the syncytiotrophoblast in the human placenta. Infect. Immun. 1997; 65: 1251-7.
4. Crandall I, Land KM, Sherman IW. Plasmodium falciparum: pfalhesin and CD36 form an adhesin/receptor pair that is responsible for the pH-dependent portion of cytoadherence/sequestration. Exp. Parasitol. 1994; 78: 203-9.
5. Ockenhouse CF, Klotz FW, Tandon NN, Jamieson GA. Sequestrin, a CD36 recognition protein on Plasmodium falciparum malaria-infected erythrocytes identified by anti-idiotype antibodies. Proc. Natl Acad. Sci. USA 1991; 88: 3175-9.
6. Crandall I, Sherman IW. Plasmodium falciparum (human malaria)-induced modifications in human erythrocyte band 3 protein. Parasitology 1991; 102: 335-40.
7. Smith H, Crandall I, Prudhomme J, Sherman IW. Optimization and inhibition of the adherent ability of Plasmodium falciparum-infected erythrocytes. Mem. Inst. Oswaldo Cruz 1992; 87: 303-12.
8. Trenholme KR, Gardiner DL, Holt DC, Thomas EA, Cowman AF, Kemp DJ. Clag9 - a cytoadherence gene in Plasmodium falciparum essential for binding of parasitized erythrocytes to CD36. Proc. Natl Acad. Sci. USA 2000; 97: 4029-33.
9. Waller KL, Cooke BM, Nunomura W, Mohandas N, Coppel R. Mapping the binding domains involved in the interaction between the Plasmodium falciparum knob-associated histidine-rich protein (KAHRP) and the cytoadherence ligand P. falciparum erythrocyte membrane protein 1 (PfEMP1). J. Biol. Chem. 1999; 274: 23 808-13.
10. Baruch DI, Pasloske BL, Singh HB et al. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 1995; 82: 77-87.
11. Su XZ, Heatwole VM, Wertheimer SP et al. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 1995; 82: 89-100.
12. Smith JD, Chitnis CE, Craig AG et al. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 1995; 82: 101-10.
13. Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 1989; 341: 57-9.
14. Ockenhouse CF, Tegoshi T, Maeno Y et al. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular adhesion molecule 1. J. Exp. Med. 1992; 176: 1183-9.
15. Roberts DD, Sherwood JA, Spitalnik SL et al. Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature 1985; 318: 64-6.
16. Rogerson SJ, Chaiyaroj SC, Ng K, Reeder JC, Brown GV. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J. Exp. Med. 1995; 182: 15-20.
17. Taylor TE, Molyneux M, Wirima J, Borgstein A, Goldring J, Hommel M. Intravenous immunoglobulin in the treatment of paediatric cerebral malaria. Clin. Exp. Immunol. 1992; 90: 357-62.
18. Cohen S, McGregor IA, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961; 192: 733-7.
19. Sabchareon A, Burnouf T, Ouattara D et al. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 1991; 45: 297-308.
20. David PH, Hommel M, Miller LH, Udeinya IJ, Oligino LD. Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc. Natl Acad. Sci. USA 1983; 80: 5075-9.
21. Singh B, Ho M, Looareesuwan S, Mathai E, Warrell DA, Hommel M. Plasmodium falciparum: inhibition/reversal of cytoadherence of Thai isolates to melanoma cells by local immune sera. Clin. Exp. Immunol. 1988; 72: 145-50.
22. Goldring JPD, Wirima J, Molyneux M, Taylor T, Hommel M. Plasmodium falciparum: diversity of isolates from Malawi in their cytoadherence to melanoma cells and monocytes in vitro. Br. J. Haematol. 1992; 81: 413-18.
23. Udomsangpetch R., Aikawa M, Berzins K, Wahlgren M, Perlmann P. Cytoadherence of knobless Plasmodium falciparum-infected erythrocytes and its inhibition by human monoclonal antibody. Nature 1989; 338: 763-5.
24. Iqbal J, Perlmann P, Berzins K. Plasmodium falciparum: Analysis of the cytoadherence inhibition of the human monoclonal antibody 33G2 and of antibodies reactive with antigen Pf 332. Exp. Parasitol. 1993; 77: 79-87.
25. Johnson JK, Swerlick RA, Grady KK, Millet P, Wick TM. Cytoadherence of Plasmodium falciparum-infected erythrocytes to microvasculature endothelium is regulatable by cytokines and phorbol ester. J. Infect. Dis. 1993; 167: 698-703.
26. Sherwood JA, Roberts DD, Spitalnik S et al. Studies of the receptors on melanoma cells for Plasmodium falciparum infected erythrocytes. Am. J. Trop. Med. Hyg. 1989; 40: 119-27.
27. Crandall I, Collins WE, Gysin J, Sherwin IW. Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum. Proc. Natl Acad. Sci. USA 1993; 90: 4703-7.
28. Nagao E, Kaneko O, Dvorak J. Plasmodium falciparum infected erythrocytes: qualitative and quantitative analyses of parasite induced knobs by atomic force microscopy. J. Struct. Biol. 2000; 130: 24-44.
29. Berkow R, Beers MH, Fletcher AJ. Merck Manual of Medical Information, Home edition. Whitehouse, NJ: Merck, 1997.
30. Henninger DD, Panes J, Eppihimer M et al. Cytokine induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J. Immunol. 1997; 158: 1825-32.
31. Graninger W, Prada J, Neifer S, Zotter G, Thalhammer F, Kremsner PG. Upregulation of ICAM-1 by Plasmodium falciparum in vitro and in vivo studies. J. Clin. Pathol. 1994; 47: 653-6.
32. Thibert V, Bellucci S, Edelman L, Tandon NN, Legrand C. Quantitation of platelet glycoprotein IV (CD36) in healthy subjects and in patients with essential thrombocythemia using immunocapture assay. Thromb. Haemost. 1992; 68: 600-5.
33. Barnwell JW, Ockenhouse CF, Knowles DM. Monoclonal antibody OKM5 inhibits in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and C32 melanoma cells. J. Immunol. 1985; 135: 3493-7.
34. Ruangjirachuporn W, Afzelius BA, Helmby H et al. Ultrastructural analysis of fresh Plasmodium falciparum-infected erythrocytes and their cytoadherence to human leukocytes. Am. J. Trop. Med. Hyg. 1992; 46: 511-19.
35. Morty RE, Lonsdale-Eccles JD, Mentele R, Auerswald EA, Coetzer THT. Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity. Infect. Immun. 2001; 69: 2757-61.
36. Hatabu T, Kawazu S, Aikawa M, Kano S. Binding of Plasmodium falciparum infected erythrocytes to the membrane-bound form of Fractakline/CX3CL1. Proc. Natl Acad. Sci. USA 2003; 100: 15 942-6.
37. Vogt AM, Barragan A, Chen Q, Kironde F, Spillmann D, Wahlgren M. Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood 2003; 101: 2405-11.
38. Beeson JG, Rogerson SJ, Brown GV. Evaluating specific adhesion of Plasmodium falciparum-infected erythrocytes to immobilised hyaluronic acid with comparison to binding of mammalian cells. Int. J. Parasitol. 2002; 32: 1245-52.
39. Gura T. Magic bullets hit the target. Nature 2002; 417: 584-6.
40. Sgro C. Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review. Toxicology 1995; 105: 23-9.
41. Hudson L, Hey FC. Practical Immunology, 3rd edn. London: Blackwell Scientific Publications, 1991.
42. Goldring JPD, Nemaorani S. Antimalarial drugs modulate the expression of monocyte receptors. Int. J. Immunopharmacol. 1999; 21: 599-607.
43. Goldring JPD, Padayachee T, Ismail I. Plasmodium falciparum malaria: Rosettes are disrupted by quinine, artemesinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil. Mem. Inst. Oswaldo Cruz 1999; 94: 667-74.
44. Goldring JPD, Ramoshebi N. Glucocorticoids, antioxidants and staurosporine modulate the adherence between monocytes and malaria infected erythrocytes. Inflamm. Res. 1999; 48: 657-61.
45. Grau GE, Taylor TE, Molyneux ME et al. Tumour necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 1989; 320: 1586-91.
46. Kern P, Hemmer CJ, Van Damme J, Gruss HJ, Dietrich M. Elevated tumour necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 1989; 87: 139-43.
47. Mattila P, Majuri ML, Mattila PS, Renkonen R. TNF alpha-induced expression of endothelial adhesion molecules, ICAM-1 and VCAM-1, is linked to protein kinase C activation. Scand. J. Immunol. 1992; 36: 159-65.
48. Wickramasinghe SN, Phillips RE, Looareesuwan S, Warrell DA, Hughes M. The bone marrow in human cerebral malaria: parasite sequestration within sinusoids. Br. J. Haematol. 1987; 66: 295-306.
49. Murohara T, Delyani JA, Albelda SM, Lefer AM. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J. Immunol. 1996; 156: 3550-57.
50. Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect. Immun. 2003; 71: 6620-23.
51. Maubert B, Fievet N, Tami G, Boudin C, Deloron P. Cytoadherence of Plasmodium falciparum-infected erythrocytes in the human placenta. Parasite Immunol. 2000; 22: 191-9.